SCHEMBL13071027

SCHEMBL13071027

CCC1CC2(CC2)CN1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17987072 1.00
SCHEMBL18462894 0.91 HDAC6 (0.30)
SCHEMBL22943752 0.89 HDAC6 (0.32)
SCHEMBL22944864 0.89 HDAC6 (0.32)
SCHEMBL4547463 0.79 HTT (0.30)
SCHEMBL17621235 0.79 HDAC6 (0.33)
SCHEMBL16271221 0.79 HTT (0.30)
SCHEMBL16187693 0.79
SCHEMBL21897219 0.77
SCHEMBL18462678 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170029408-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. 2017-02-02 US disclosed
WO-2014131315-A1 BRIDGED RING COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2014-09-04 WO disclosed
WO-2014082379-A1 SPIRO RING COMPOUND AS HEPATITIS C VIRUS (HCV) INHIBITOR AND USES THEREOF FIELD OF THE INVENTION SUNSHINE LAKE PHARMA CO.,LTD. (CN) 2014-06-05 WO disclosed
WO-2010132601-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. (US) 2010-11-18 WO disclosed